Basit öğe kaydını göster

Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: A randomized trial

dc.contributor.authorSut, Necdet
dc.contributor.authorMert, A
dc.contributor.authorOzbay, Gülşen
dc.contributor.authorTabak, F
dc.contributor.authorMidilli, Kenan
dc.contributor.authorOzaras, Reşat
dc.contributor.authorCanbakan, B
dc.contributor.authorSenturk, H
dc.contributor.authorAkdogan, M
dc.contributor.authorTahan, V
dc.date.accessioned2021-03-03T15:48:45Z
dc.date.available2021-03-03T15:48:45Z
dc.date.issued2006
dc.identifier.citationCanbakan B., Senturk H., Tabak F., Akdogan M., Tahan V., Mert A., Sut N., Ozaras R., Midilli K., Ozbay G., "Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: A randomized trial", JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, cilt.21, sa.4, ss.657-663, 2006
dc.identifier.issn0815-9319
dc.identifier.othervv_1032021
dc.identifier.otherav_40ea6d74-1474-45d0-99a5-c0dec60ade69
dc.identifier.urihttp://hdl.handle.net/20.500.12627/47374
dc.identifier.urihttps://doi.org/10.1111/j.1440-1746.2006.04082.x
dc.description.abstractBackground and Aim: Delta hepatitis is characterized by rapidly progressive liver disease with adverse prognosis in most patients. Patients benefit from high doses and prolonged courses of interferon (IFN) therapy; however, lamivudine as a single agent has been disappointing. Data relating to the efficacy of IFN and lamivudine in combination is limited. The aim of this study was to test the efficacy of IFN-alpha 2b and lamivudine combination treatment in comparison to IFN-alpha 2b alone in patients with chronic delta hepatitis.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectGastroenteroloji-(Hepatoloji)
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectGASTROENTEROLOJİ VE HEPATOLOJİ
dc.titleEfficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: A randomized trial
dc.typeMakale
dc.relation.journalJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
dc.contributor.department, ,
dc.identifier.volume21
dc.identifier.issue4
dc.identifier.startpage657
dc.identifier.endpage663
dc.contributor.firstauthorID41156


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster